The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk
Authors
Keywords
-
Journal
Clinical Research in Cardiology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-20
DOI
10.1007/s00392-021-01815-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Serum Uric Acid with Metabolic Syndrome and Its Components: A Mendelian Randomization Analysis
- (2020) Lu Wang et al. Biomed Research International
- Characterization of the Inflammatory‐Metabolic Phenotype of Heart Failure and a Preserved Ejection Fraction: a Hypothesis to Explain Influence of Sex on the Evolution and Potential Treatment of the Disease
- (2020) Milton Packer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF
- (2020) Senthil Selvaraj et al. EUROPEAN JOURNAL OF HEART FAILURE
- Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
- (2019) Sunao Kojima et al. EUROPEAN HEART JOURNAL
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years
- (2019) Agostino Virdis et al. HYPERTENSION
- Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population
- (2018) Michele Bombelli et al. JOURNAL OF HYPERTENSION
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
- (2018) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
- (2018) Kenjiro Kimura et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
- (2017) Xue Li et al. BMJ-British Medical Journal
- Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
- (2017) Xue Li et al. BMJ-British Medical Journal
- Serum uric acid and the risk of cardiovascular and renal disease
- (2015) Claudio Borghi et al. JOURNAL OF HYPERTENSION
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
- (2013) T. M. Palmer et al. BMJ-British Medical Journal
- Useful tests of usefulness of new risk factors: Tools for assessing reclassification and discrimination
- (2011) Johan Sundström et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started